ABHD10 Inhibitors

ABHD10 inhibitors constitute a diverse group of compounds that modulate the enzymatic activity of ABHD10, primarily involved in lipid metabolism. MAFP, MAFP benzyl, and RHC 80267 directly inhibit ABHD10 by binding to its active site, disrupting the hydrolase activity and impeding the breakdown of substrates, such as lysophosphatidylserine. These inhibitors play a crucial role in modulating ABHD10's catalytic function, influencing lipid metabolism and cellular signaling pathways.

Selective inhibitors, including JZL195, WWL123, and KML29, specifically target ABHD10, impeding the hydrolysis of lysophosphatidylserine. This targeted inhibition leads to the accumulation of lysophosphatidylserine and influences ABHD10 activity, impacting cellular processes and lipid homeostasis. Additionally, compounds like KT182, URB602, WWL70, WWL70 analog, and TMP269 provide alternative means of inhibiting ABHD10 by disrupting the hydrolysis of key substrates, such as lysophosphatidylserine or 2-arachidonoylglycerol, affecting lipid metabolism and cellular signaling pathways. In conclusion, ABHD10 inhibitors exhibit diverse mechanisms, from general serine hydrolase inhibition to selective disruption of specific substrates. Understanding these inhibitors' modes of action provides valuable insights into strategies for modulating ABHD10 activity in the context of lipid metabolism and cellular signaling.